Tenkasi 400 mg

Tenkasi 400 mg is a medicine authorised by Swissmedic under authorisation number 68135. The authorisation holder is A. Menarini GmbH. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 07 April 2022 and the authorisation is limited until 06 April 2027. ATC code J01XA05 places the medicine in the group Antibacterials for systemic use.

  • Dispensing category A
  • Authorisation number 68135
  • ATC J01XA05
  • Synthetic medicines
Authorisation data
Authorisation number68135
NameTenkasi 400 mg
Full nameTenkasi 400 mg, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
Authorisation holderA. Menarini GmbH
Medicinal product codeSynthetic medicines
Dispensing categoryA · Prescription, not repeatable
ATC codeJ01XA05
First authorisation07 April 2022
Authorisation validity06 April 2027
Strengths
No.NameDispensing categoryAuthorisation date
1Tenkasi 400 mg, Pulver für ein Konzentrat zur Herstellung einer InfusionslösungA07 April 2022
2Tenkasi 1200 mg, Pulver für ein Konzentrat zur Herstellung einer InfusionslösungA10 October 2024

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
13Durchstechflasche(n)J01XA0508.01.9.A
21Durchstechflasche(n)J01XA0508.01.9.A

Scroll the table sideways

Other medicines from this authorisation holder

Frequently asked questions

Is Tenkasi 400 mg authorised in Switzerland?

Yes. Tenkasi 400 mg is authorised by Swissmedic under authorisation number 68135, data as of 01 September 2026. The authorisation is limited until 06 April 2027.

Which dispensing category does Tenkasi 400 mg have?

Tenkasi 400 mg is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.

Who is the authorisation holder of Tenkasi 400 mg?

The authorisation holder is A. Menarini GmbH. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com